Cambridge, United Kingdom

Susanne Taylor

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Susanne Taylor: Pioneering Innovations in Tyrosine Kinase Inhibitors

Introduction

Susanne Taylor, an accomplished inventor based in Cambridge, GB, has made significant contributions to the field of medicinal chemistry through her innovative research. With a total of two patents to her name, she is recognized for her groundbreaking work on tyrosine kinase inhibitors, which hold promising implications for cancer therapies.

Latest Patents

Susanne's latest inventions include her work on oxazole tyrosine kinase inhibitors. These compounds are characterized as amides with a specific molecular formula and structure, including variations such as salts, solvates, N-oxides, or tautomers. The compounds target key kinases, notably FLT3, FLT4, and Aurora kinases, which are crucial in the regulation of various cellular processes. This invention has the potential to pave the way for new treatments in oncology, showcasing her expertise and innovative spirit.

Career Highlights

Susanne Taylor is currently affiliated with Sareum Limited, a company renowned for its dedication to drug discovery and development. Her role as an inventor plays a critical part in advancing the company’s goals of delivering novel therapeutic solutions. With a keen focus on kinase inhibitors, she continues to contribute to the scientific community and the advancement of medical knowledge.

Collaborations

Throughout her career, Susanne has collaborated with notable professionals in the field, including John Charles Reader and John Mark Ellard. Their joint efforts have facilitated the exchange of ideas and fostered innovation in their research endeavors, further enhancing the productivity and success of their projects.

Conclusion

In conclusion, Susanne Taylor stands out as a visionary inventor in the realm of tyrosine kinase inhibitors. Her contributions, encapsulated in her patents, reflect a commitment to improving health outcomes through innovative science. As she continues her work at Sareum Limited, the medical field awaits with anticipation for her next groundbreaking discoveries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…